Pamapimod
A potent, selective, orally bioavailable p38α MAPK inhibitor with Kd of 0.2 nM; displays >100 fold selectivity over p38β (Kd=29 nM), and no affinity against p38γ, p38δ and a broad panel of kianses; inhibits LPS-stimulated TNF-alpha production by monocytes, IL-1beta production in human whole blood; exhibits the ability to inhibit the signs and symptoms of RA and other autoimmune diseases.Rheumatoid Arthritis Phase 2 Discontinued.
Product Specifications
CAS Number
449811-01-2
Product Name Alternative
Ro4402257 | R1503
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 34 mg/mL
Smiles
O=C1C (OC2=CC=C (F) C=C2F) =CC3=CN=C (NC (CCO) CCO) N=C3N1C
Molecular Formula
C19H20F2N4O4
Molecular Weight
406.3833
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Pyrido[2,3-d]pyrimidin-7 (8H) -one, 6- (2,4-difluorophenoxy) -2-[[3-hydroxy-1- (2-hydroxyethyl) propyl]amino]-8-methyl-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-CD55 Antibody Picoband® (monoclonal, 9F3A1), HRP Conjugate
2-Methyl-1- (pyrrolidin-2-ylmethyl) -1H-1,3-benzodiazole
2-Methyl-1- (pyrrolidin-2-ylmethyl) -1H-1,3-benzodiazole
